Read + Share
Amedeo Smart
Independent Medical Education
Jack GA, Avenatti E, Kashyap SR, Sadhu AR, et al. Overcoming Disparities in Using SGLT2 Inhibitors for Cardiorenal Protection in Persons With and Without Type 2 Diabetes. J Clin Endocrinol Metab 2025 May 27:dgaf301. doi: 10.1210.PMID: 40420813
Email
LinkedIn
Privacy Policy